Table of Content


Introduction
Heterozygous familial hypercholesterolemia - Overview
Heterozygous familial hypercholesterolemia - Therapeutics Development
Heterozygous familial hypercholesterolemia - Therapeutics Assessment
Heterozygous familial hypercholesterolemia - Companies Involved in Therapeutics Development
Heterozygous familial hypercholesterolemia - Drug Profiles
Heterozygous familial hypercholesterolemia - Dormant Projects
Heterozygous familial hypercholesterolemia - Discontinued Products
Heterozygous familial hypercholesterolemia - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by AD Pharmaceuticals Co Ltd, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Beijing Mabworks Biotech Co Ltd, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Innovent Biologics Inc, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by LIB Therapeutics LLC, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Madrigal Pharmaceuticals Inc, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by NeuroBo Pharmaceuticals Inc, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Novartis AG, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Regeneron Pharmaceuticals Inc, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Verve Therapeutics Inc, 2021
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, 2021
Heterozygous familial hypercholesterolemia (heFH) - Dormant Projects, 2021
Heterozygous familial hypercholesterolemia (heFH) - Discontinued Products, 2021